UEFISCDI — Executive Agency for Higher Education, Research, Development & Innovation Funding (Unitatea Executivă pentru Finanțarea Învățământului Superior, a Cercetării, Dezvoltării și Inovării) logo
UEFISCDI Transnational & ERA-NET Calls

TRANSCAN-4 — Translational Research on Cancer Metabolism

Offers Romanian cancer-metabolism teams access to European collaboration through TRANSCAN 4 to advance innovation toward care.

TRANSCAN-4 2026 is an ERA-NET Cofund transnational research call focused on translational cancer metabolism research, coordinated across 21 participating countries including Austria, Belgium, Canada, France, Germany, Hungary, Israel, Italy, Malta, Poland, Slovakia, Spain, Taiwan, and Turkey. The coordinating organization is AICIB in Portugal, and the partnership implementation period runs from 202…

Transnational translational research on cancer metabolism, including metabolic biomarkers, tumor metabolic vulnerabilities, and precision medicine approaches, within a 21-country ERA-NET consortium co-funded by UEFISCDI with EUR 1,000,000 for Romanian partners.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.One-off
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.36–48 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.€1M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Guides for this application

All guides →
European Commission logo
Scheduled

Clinical Research for Common Cancers

🇪🇺European Commission · European Union

Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.

MedtechBiotech+1
€7M – €10MSep'27
European Commission logo
Scheduled

Cancer Mission: Functional Genomics for New Treatments

🇪🇺European Commission · European Union

Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.

BiotechMedtech+2
€7M – €8MSep'27
European Commission logo
Scheduled

Cancer Mission: First-in-Human Trials for Rare Cancers

🇪🇺European Commission · European Union

Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.

BiotechMedtech+1
€7M – €9MSep'27
European Commission logo
Scheduled

Mission Soil and Cancer: Living Labs for Carcinogenic Contamination

🇪🇺European Commission · European Union

Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.

Climate TechMedtech+2
€12MSep'27
European Commission logo
Scheduled

Equitable Cancer Care Economics and Outcomes

🇪🇺European Commission · European Union

Funds three €5–7M projects that make cancer control more equitable, effective and cost-aware for patients and families.

MedtechBiotech
€5M – €7MSep'27
European Commission logo
Scheduled

Pre-Commercial Procurement for Cancer Care

🇪🇺European Commission · European Union

Funds €8–10M procurer consortia to bring affordable cancer technologies, devices and medicines from tender to patient benefit.

MedtechBiotech+1
€8M – €10MSep'27